RecruitingNAINTERVENTIONAL

Impact of a Personalized Medication Plan on Duration of Treatment With Potent Opioids in Acute Non-cancer Musculoskeletal Pain.

Doctors are trying to find out if giving people with sudden, severe muscle and joint pain a special, personalised plan for their pain relief can make a difference. This plan focuses on strong pain medicines called opioids. The study aims to see if patients who receive this tailored support use these medicines for a shorter period compared to those who get standard care. The main idea is to help patients understand their medication better and hopefully reduce the risk of becoming too reliant on these strong painkillers. It's for adults with non-cancer related pain who are in hospital and starting or continuing a strong opioid treatment.

At a glance

Status

Recruiting

Phase

Sponsor

University Hospital, Rouen

Enrolment target

200

Start

18 Jan 2024

Estimated completion

18 Jul 2028

Acute Pathology of the Locomotor System

What is this study about?

When you have sudden, severe pain in your muscles, bones, or joints that isn't from cancer or a major injury, doctors sometimes prescribe strong pain medicines called opioids. While these can be very effective, there's always a concern about using them for too long and potentially becoming dependent.

This study is looking into a new approach. They want to see if providing a personalised plan for managing these strong pain medicines makes a difference. This isn't just about giving out medicine; it's about making sure you're well-informed and understand exactly why you're taking it and for how long. The aim is to help you feel better while also reducing the time you need to take these powerful medications.

The main goal is to find out if patients who get this special, personalised support use strong opioids for a shorter duration. This could mean a lower chance of developing a dependence on them, compared to people who receive the usual care for their pain. It's about finding safer and more effective ways to manage acute pain in the hospital setting.

Key takeaways

A study for adults with sudden, non-cancer muscle/joint pain in hospital.
It aims to see if a personalised pain plan helps use strong opioids for less time.
Could help reduce the risk of becoming dependent on strong painkillers.
The personalised plan focuses on informing and educating patients about their medicine.
You can stop participating at any point without affecting your care.

Who may be eligible?

This study is for adults, aged 18 and over, who are currently in hospital for pain in their muscles, bones, or joints. This pain should be new and not caused by cancer or a major accident. You would be considered if you are just starting to take strong opioid pain medication, or if you are already taking it but have been on it for less than 30 days.

There are some reasons why you wouldn't be able to join. If you have cancer or fibromyalgia already, or if you've been taking strong opioid medicine for more than 30 days, this study isn't for you. Also, if you don't speak French well enough to understand the study details, or if the doctors or pharmacists feel you can't manage your pain medication safely on your own, you wouldn't be eligible. Lastly, if you've already taken part in this specific study, you can't join again.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you 18 years old or older?
Are you currently in hospital for muscle, bone, or joint pain?
Is your pain new and NOT related to cancer or a major injury?
Are you starting strong pain medication, or have you been on it for less than 30 days?
Can you understand information in French?

Answer every question to see your result.

What does participation involve?

As this information is limited, the study brief doesn't detail what your participation would involve beyond receiving a personalised plan. Typically, in studies like this, it might mean more regular check-ins with your healthcare team, special educational materials about your pain medication, and potentially answering questions about your pain levels and how you're feeling. The length of your participation would likely be tied to the duration of your hospital stay and how long you are prescribed strong opioids, with follow-up appointments possible after discharge. The total duration for each person isn't specified but would likely be over a few weeks to assess the impact of the plan.

Potential risks and benefits

Taking part could offer the benefit of a more tailored approach to managing your pain, potentially leading to a shorter time on strong painkillers and a reduced risk of becoming dependent on them. However, as with any medical treatment, there's always a chance the personalised plan might not work as well for everyone, or that you might still experience side effects from the medication. You are completely free to withdraw from the study at any time, for any reason, without it affecting your medical care.

Locations (3)

CHU de Lille
Verified postcode
Lille, France· Recruiting
CHU de Nimes
Verified postcode
Nîmes, France· Recruiting
CHU de ROUEN
Verified postcode
Rouen, France· Recruiting

Common questions

What kind of pain is this study for?

It's for sudden, new pain in your muscles, bones, or joints that isn't caused by cancer or a major injury.

What are 'strong opioids'?

These are powerful pain medicines that doctors sometimes prescribe for severe pain, like morphine or oxycodone.

What does a 'personalised pharmaceutical plan' mean?

It means getting a tailored plan and information specific to you about how to best use your pain medication.

Will I have to stay in hospital longer if I join?

The study doesn't say you would. It's about managing your pain during your existing hospital stay for acute pain.

Can I leave the study if I change my mind?

Yes, you can choose to stop taking part at any time, and it won't affect your medical care.

How to find out more

Catherine CHENAILLER

catherine.chenailler@chu-rouen.fr +3323288 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.